These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 9783806
1. Expression profiles of I and sialosyl-I antigens on blood cells: the sialosyl-I antigen is expressed along the monocytic differentiation. Muroi K, Handa K, Amemiya Y, Hakomori S, Ozawa K, Miura Y. Leuk Res; 1998 Nov; 22(11):1029-36. PubMed ID: 9783806 [Abstract] [Full Text] [Related]
2. Reactivity profiles of leukemic myeloblasts with monoclonal antibodies directed to sialosyl-Le(x) and other lacto-series type 2 chain antigens:absence of reactivity with normal hematopoietic progenitor cells. Muroi K, Suda T, Nojiri H, Ema H, Amemiya Y, Miura Y, Nakauchi H, Singhal A, Hakomori S. Blood; 1992 Feb 01; 79(3):713-9. PubMed ID: 1370643 [Abstract] [Full Text] [Related]
3. Expression of sialosyl-Tn in colony-forming unit-erythroid, erythroblasts, B cells, and a subset of CD4+ cells. Muroi K, Suda T, Nakamura M, Okada S, Nojiri H, Amemiya Y, Miura Y, Hakomori S. Blood; 1994 Jan 01; 83(1):84-91. PubMed ID: 7903875 [Abstract] [Full Text] [Related]
4. Comparison of CD34+ subsets and clonogenicity in human bone marrow, granulocyte colony-stimulating factor-mobilized peripheral blood, and cord blood. Cho SH, Chung IJ, Lee JJ, Park ML, Kim HJ. J Korean Med Sci; 1999 Oct 01; 14(5):520-5. PubMed ID: 10576147 [Abstract] [Full Text] [Related]
5. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Bender JG, Unverzagt KL, Walker DE, Lee W, Van Epps DE, Smith DH, Stewart CC, To LB. Blood; 1991 Jun 15; 77(12):2591-6. PubMed ID: 1710512 [Abstract] [Full Text] [Related]
6. Further investigations on the expression of HLA-DR, CD33 and CD13 surface antigens in purified bone marrow and peripheral blood CD34+ haematopoietic progenitor cells. Pierelli L, Teofili L, Menichella G, Rumi C, Paoloni A, Iovino S, Puggioni PL, Leone G, Bizzi B. Br J Haematol; 1993 May 15; 84(1):24-30. PubMed ID: 7687858 [Abstract] [Full Text] [Related]
7. Biological characterization of CD34+ cells mobilized into peripheral blood. Lemoli RM, Tafuri A, Fortuna A, Catani L, Rondelli D, Ratta M, Tura S. Bone Marrow Transplant; 1998 Dec 15; 22 Suppl 5():S47-50. PubMed ID: 9989890 [Abstract] [Full Text] [Related]
8. Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens. Sakabe H, Ohmizono Y, Tanimukai S, Kimura T, Mori KJ, Abe T, Sonoda Y. Stem Cells; 1997 Dec 15; 15(1):73-81. PubMed ID: 9007225 [Abstract] [Full Text] [Related]
9. Comparison of the phenotype and clonogenicity of normal CD34+ cells from umbilical cord blood, granulocyte colony-stimulating factor-mobilized peripheral blood, and adult human bone marrow. Steen R, Tjønnfjord GE, Egeland T. J Hematother; 1994 Dec 15; 3(4):253-62. PubMed ID: 7537606 [Abstract] [Full Text] [Related]
10. Flow cytometric characterization of CD34+ hematopoietic progenitor cells in mobilized peripheral blood and bone marrow of cancer patients. D'Arena G, Cascavilla N, Musto P, Greco M, Di Mauro L, Carella AM, Dello Iacono N, Carotenuto M. Haematologica; 1996 Dec 15; 81(3):216-23. PubMed ID: 8767526 [Abstract] [Full Text] [Related]
13. GM-CSF stimulates proliferation of clonal leukemic bone marrow cells in acute myeloid leukemia (AML) in vitro. Schmetzer HM, Gerhartz HH, Wilmanns W. Ann Hematol; 1999 Oct 15; 78(10):449-55. PubMed ID: 10550555 [Abstract] [Full Text] [Related]
14. Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF). Suzuki T, Muroi K, Tomizuka H, Amemiya Y, Miura Y. Stem Cells; 1995 May 15; 13(3):273-80. PubMed ID: 7542113 [Abstract] [Full Text] [Related]
15. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood. Fritsch G, Stimpfl M, Kurz M, Printz D, Buchinger P, Fischmeister G, Hoecker P, Gadner H. Bone Marrow Transplant; 1996 Feb 15; 17(2):169-78. PubMed ID: 8640162 [Abstract] [Full Text] [Related]
16. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor. Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, Benini C, Tura S. Exp Hematol; 1993 Dec 15; 21(13):1668-72. PubMed ID: 7694867 [Abstract] [Full Text] [Related]
17. Characterization of peripheral blood CD34+ progenitor cells mobilized with chemotherapy and granulocyte colony-stimulating factor. Teofili L, Iovino MS, Sica S, Pierelli L, Menichella G, De Stefano V, Rumi C, Leone G. Exp Hematol; 1994 Sep 15; 22(10):990-5. PubMed ID: 7522187 [Abstract] [Full Text] [Related]
18. Increased levels of CD34+ hemopoietic progenitor cells in atopic subjects. Sehmi R, Howie K, Sutherland DR, Schragge W, O'Byrne PM, Denburg JA. Am J Respir Cell Mol Biol; 1996 Nov 15; 15(5):645-55. PubMed ID: 8918371 [Abstract] [Full Text] [Related]
19. Effects of anti-CD33 blocked ricin immunotoxin on the capacity of CD34+ human marrow cells to establish in vitro hematopoiesis in long-term marrow cultures. La Russa VF, Griffin JD, Kessler SW, Cutting MA, Knight RD, Blattler WA, Lambert JM, Wright DG. Exp Hematol; 1992 May 15; 20(4):442-8. PubMed ID: 1373688 [Abstract] [Full Text] [Related]
20. [Expression of AC133 vs. CD34 in acute childhood leukemias]. Ebener U, Brinkmann A, Zotova V, Niegemann E, Wehner S. Klin Padiatr; 2000 May 15; 212(3):90-8. PubMed ID: 10916777 [Abstract] [Full Text] [Related] Page: [Next] [New Search]